Development of a Combined Digital and Biomarker Test for Bipolar Disorder

In this webinar, Sabine Bahn, Professor of Neurotechnology at the University of Cambridge and Director of the Cambridge Centre for Neuropsychiatric Research, will be sharing her findings on the development of a combined digital and biomarker test for Bipolar Disorder.

Professor Sabine Bahn is a practising psychiatrist, Chair in Neurotechnology and Director of the Cambridge Centre for Neuropsychiatric Research at Cambridge University. Her main research interests are to understand the molecular basis of neuropsychiatric disorders, with a focus on schizophrenia and mood disorders. Professor Bahn has published many articles in high impact journals. In 2005, she co-founded Psynova Neurotech Ltd, which has launched the first blood test aiding in the early diagnosis of schizophrenia. In 2011 Psynova Neurotech was acquired by Myriad Genetics, a NASDAQ listed company. In 2015 she co-founded Psyomics Ltd, which aims to transform mental health through digital diagnosis. In 2015 she was elected as Fellow of the Royal Society of Biology. She is a fellow of Lucy Cavendish College. You can find details of her upcoming program on

Translate »